E. Høiby

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland.

B. Plikaytis, C. Broome, G. Carlone, 1998, The Journal of infectious diseases.

Functional Activities and Epitope Specificity of Human and Murine Antibodies against the Class 4 Outer Membrane Protein (Rmp) of Neisseria meningitidis

J. Tommassen, E. Rosenqvist, E. Namork, 1999, Infection and Immunity.

Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine.

F. Oftung, T. Michaelsen, E. Høiby, 1999, Vaccine.

Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule.

D. Caugant, I. Aaberge, E. Høiby, 2010, Vaccine.

Outer membrane vesicle vaccines made from short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis: effect of the carbohydrate chain length on the immune response.

T. Michaelsen, G. Bjune, E. Jantzen, 1997, Vaccine.

Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage*

D. Stein, N. Phillips, E. Rosenqvist, 2015, The Journal of Biological Chemistry.

Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis.

J. V. D. van der Meer, M. van Deuren, P. Brandtzaeg, 2003, Blood.